Report Detail

Summary:
Non-invasive liquid biopsy is to analyze and diagnose diseases such as cancer through blood or urine and other body fluids. At present, the main application area of liquid biopsy is the blood detection of tumors, that is, the use of blood to indicate tumor development and drug resistance and other information to guide individualized and precise treatment. Compared with existing tumor detection methods, liquid biopsy is non-invasive, can be detected frequently and repeatedly, and has rapid response capabilities. It has significant advantages and has great potential for application development.
Market Insights
QY Research has lately published a report titled “Global Non-Invasive Liquid Biopsy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Non-Invasive Liquid Biopsy market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Stool Test
Urine Test
Saliva Test
Others
Segment by Application
Hospital
Laboratory
Others

Regional Scope
This segment of the report offers a thorough regional study of the global Non-Invasive Liquid Biopsy market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Bio-Techne
Endress + Hauser
Exact Sciences Corporation
Lonza Group AG
MDxHealth
Merck KGaA
MutantDx
Norgen Biotek Corp
Nucleix
Oasis Diagnostics Corporation
OraSure Technologies
PerkinElmer
Predicine
Qiagen
Thermo Fisher Scientific
Zymo Research Corporation

Frequently Asked Questions
Which application segment captured the leading share in the Non-Invasive Liquid Biopsy market?
How fragmented is the Non-Invasive Liquid Biopsy market?
Which are the key growth drivers in the Non-Invasive Liquid Biopsy market?
Which are the top strategies undertaken by the Non-Invasive Liquid Biopsy market players?
Which technological trends are likely to affect the Non-Invasive Liquid Biopsy market?
What is the expected Non-Invasive Liquid Biopsy market size by 2027?
Which companies are dominating the Non-Invasive Liquid Biopsy market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Non-Invasive Liquid Biopsy market growth?
Which are the emerging companies in the Non-Invasive Liquid Biopsy market?


Table of Contents

    1 Market Overview of Non-Invasive Liquid Biopsy

    • 1.1 Non-Invasive Liquid Biopsy Market Overview
      • 1.1.1 Non-Invasive Liquid Biopsy Product Scope
      • 1.1.2 Non-Invasive Liquid Biopsy Market Status and Outlook
    • 1.2 Global Non-Invasive Liquid Biopsy Market Size Overview by Region 2016 VS 2021 VS 2027
    • 1.3 Global Non-Invasive Liquid Biopsy Market Size by Region (2016-2027)
    • 1.4 Global Non-Invasive Liquid Biopsy Historic Market Size by Region (2016-2021)
    • 1.5 Global Non-Invasive Liquid Biopsy Market Size Forecast by Region (2022-2027)
    • 1.6 Key Regions, Non-Invasive Liquid Biopsy Market Size (2016-2027)
      • 1.6.1 North America Non-Invasive Liquid Biopsy Market Size (2016-2027)
      • 1.6.2 Europe Non-Invasive Liquid Biopsy Market Size (2016-2027)
      • 1.6.3 Asia-Pacific Non-Invasive Liquid Biopsy Market Size (2016-2027)
      • 1.6.4 Latin America Non-Invasive Liquid Biopsy Market Size (2016-2027)
      • 1.6.5 Middle East & Africa Non-Invasive Liquid Biopsy Market Size (2016-2027)

    2 Non-Invasive Liquid Biopsy Market Overview by Type

    • 2.1 Global Non-Invasive Liquid Biopsy Market Size by Type: 2016 VS 2021 VS 2027
    • 2.2 Global Non-Invasive Liquid Biopsy Historic Market Size by Type (2016-2021)
    • 2.3 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Type (2022-2027)
    • 2.4 Stool Test
    • 2.5 Urine Test
    • 2.6 Saliva Test
    • 2.7 Others

    3 Non-Invasive Liquid Biopsy Market Overview by Application

    • 3.1 Global Non-Invasive Liquid Biopsy Market Size by Application: 2016 VS 2021 VS 2027
    • 3.2 Global Non-Invasive Liquid Biopsy Historic Market Size by Application (2016-2021)
    • 3.3 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Application (2022-2027)
    • 3.4 Hospital
    • 3.5 Laboratory
    • 3.6 Others

    4 Non-Invasive Liquid Biopsy Competition Analysis by Players

    • 4.1 Global Non-Invasive Liquid Biopsy Market Size by Players (2016-2021)
    • 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Invasive Liquid Biopsy as of 2020)
    • 4.3 Date of Key Players Enter into Non-Invasive Liquid Biopsy Market
    • 4.4 Global Top Players Non-Invasive Liquid Biopsy Headquarters and Area Served
    • 4.5 Key Players Non-Invasive Liquid Biopsy Product Solution and Service
    • 4.6 Competitive Status
      • 4.6.1 Non-Invasive Liquid Biopsy Market Concentration Rate
      • 4.6.2 Mergers & Acquisitions, Expansion Plans

    5 Company (Top Players) Profiles and Key Data

    • 5.1 Bio-Techne
      • 5.1.1 Bio-Techne Profile
      • 5.1.2 Bio-Techne Main Business
      • 5.1.3 Bio-Techne Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.1.4 Bio-Techne Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.1.5 Bio-Techne Recent Developments
    • 5.2 Endress + Hauser
      • 5.2.1 Endress+Hauser Profile
      • 5.2.2 Endress+Hauser Main Business
      • 5.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.2.4 Endress+Hauser Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.2.5 Endress+Hauser Recent Developments
    • 5.3 Exact Sciences Corporation
      • 5.3.1 Exact Sciences Corporation Profile
      • 5.3.2 Exact Sciences Corporation Main Business
      • 5.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.3.4 Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.3.5 Lonza Group AG Recent Developments
    • 5.4 Lonza Group AG
      • 5.4.1 Lonza Group AG Profile
      • 5.4.2 Lonza Group AG Main Business
      • 5.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.4.4 Lonza Group AG Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.4.5 Lonza Group AG Recent Developments
    • 5.5 MDxHealth
      • 5.5.1 MDxHealth Profile
      • 5.5.2 MDxHealth Main Business
      • 5.5.3 MDxHealth Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.5.4 MDxHealth Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.5.5 MDxHealth Recent Developments
    • 5.6 Merck KGaA
      • 5.6.1 Merck KGaA Profile
      • 5.6.2 Merck KGaA Main Business
      • 5.6.3 Merck KGaA Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.6.4 Merck KGaA Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.6.5 Merck KGaA Recent Developments
    • 5.7 MutantDx
      • 5.7.1 MutantDx Profile
      • 5.7.2 MutantDx Main Business
      • 5.7.3 MutantDx Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.7.4 MutantDx Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.7.5 MutantDx Recent Developments
    • 5.8 Norgen Biotek Corp
      • 5.8.1 Norgen Biotek Corp Profile
      • 5.8.2 Norgen Biotek Corp Main Business
      • 5.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.8.4 Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.8.5 Norgen Biotek Corp Recent Developments
    • 5.9 Nucleix
      • 5.9.1 Nucleix Profile
      • 5.9.2 Nucleix Main Business
      • 5.9.3 Nucleix Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.9.4 Nucleix Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.9.5 Nucleix Recent Developments
    • 5.10 Oasis Diagnostics Corporation
      • 5.10.1 Oasis Diagnostics Corporation Profile
      • 5.10.2 Oasis Diagnostics Corporation Main Business
      • 5.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.10.4 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.10.5 Oasis Diagnostics Corporation Recent Developments
    • 5.11 OraSure Technologies
      • 5.11.1 OraSure Technologies Profile
      • 5.11.2 OraSure Technologies Main Business
      • 5.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.11.4 OraSure Technologies Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.11.5 OraSure Technologies Recent Developments
    • 5.12 PerkinElmer
      • 5.12.1 PerkinElmer Profile
      • 5.12.2 PerkinElmer Main Business
      • 5.12.3 PerkinElmer Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.12.4 PerkinElmer Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.12.5 PerkinElmer Recent Developments
    • 5.13 Predicine
      • 5.13.1 Predicine Profile
      • 5.13.2 Predicine Main Business
      • 5.13.3 Predicine Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.13.4 Predicine Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.13.5 Predicine Recent Developments
    • 5.14 Qiagen
      • 5.14.1 Qiagen Profile
      • 5.14.2 Qiagen Main Business
      • 5.14.3 Qiagen Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.14.4 Qiagen Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.14.5 Qiagen Recent Developments
    • 5.15 Thermo Fisher Scientific
      • 5.15.1 Thermo Fisher Scientific Profile
      • 5.15.2 Thermo Fisher Scientific Main Business
      • 5.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.15.4 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.15.5 Thermo Fisher Scientific Recent Developments
    • 5.16 Zymo Research Corporation
      • 5.16.1 Zymo Research Corporation Profile
      • 5.16.2 Zymo Research Corporation Main Business
      • 5.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Products, Services and Solutions
      • 5.16.4 Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue (US$ Million) & (2016-2021)
      • 5.16.5 Zymo Research Corporation Recent Developments

    6 North America

    • 6.1 North America Non-Invasive Liquid Biopsy Market Size by Country (2016-2027)
    • 6.2 United States
    • 6.3 Canada

    7 Europe

    • 7.1 Europe Non-Invasive Liquid Biopsy Market Size by Country (2016-2027)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Nordic
    • 7.8 Rest of Europe

    8 Asia-Pacific

    • 8.1 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2016-2027)
    • 8.2 China
    • 8.3 Japan
    • 8.4 South Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australia
    • 8.8 Rest of Asia-Pacific

    9 Latin America

    • 9.1 Latin America Non-Invasive Liquid Biopsy Market Size by Country (2016-2027)
    • 9.2 Mexico
    • 9.3 Brazil
    • 9.4 Rest of Latin America

    10 Middle East & Africa

    • 10.1 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2016-2027)
    • 10.2 Turkey
    • 10.3 Saudi Arabia
    • 10.4 UAE
    • 10.5 Rest of Middle East & Africa

    11 Non-Invasive Liquid Biopsy Market Dynamics

    • 11.1 Non-Invasive Liquid Biopsy Industry Trends
    • 11.2 Non-Invasive Liquid Biopsy Market Drivers
    • 11.3 Non-Invasive Liquid Biopsy Market Challenges
    • 11.4 Non-Invasive Liquid Biopsy Market Restraints

    12 Research Finding /Conclusion

      13 Methodology and Data Source

      • 13.1 Methodology/Research Approach
        • 13.1.1 Research Programs/Design
        • 13.1.2 Market Size Estimation
        • 13.1.3 Market Breakdown and Data Triangulation
      • 13.2 Data Source
        • 13.2.1 Secondary Sources
        • 13.2.2 Primary Sources
      • 13.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Non-Invasive Liquid Biopsy. Industry analysis & Market Report on Non-Invasive Liquid Biopsy is a syndicated market report, published as Global Non-Invasive Liquid Biopsy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Non-Invasive Liquid Biopsy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,500.00
      $7,000.00
      2,835.00
      5,670.00
      3,286.50
      6,573.00
      541,660.00
      1,083,320.00
      291,900.00
      583,800.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report